On today’s podcast, we go beyond the headlines to explore what’s driving the latest wave of GLP-1 momentum, why this represents a lasting shift rather than just another healthcare trend, the biggest misconception retailers still have about how these drugs are changing consumer behavior, and which parts of the retail playbook need to be rewritten as consumers change how they eat, shop, and live. Tune in for a discussion featuring Vice President of Content and host Suzy Davidkhanian, along with Senior Analysts Rajiv Leventhal and Rachel Wolff. Get more insights like these with our free, industry-leading newsletters covering advertising, marketing, and commerce. Sign up at emarketer.com/newsletters Follow us on Instagram at: https://www.instagram.com/emarketer/ For sponsorship opportunities contact us: advertising@emarketer.com For more information visit: https://www.emarketer.com/advertise/ Have questions or just want to say hi? Drop us a line at podcast@emarketer.com For a transcript of this episode click here: https://www.emarketer.com/content/podcast-glp-1-weight-loss-revolution-retail-s-next-big-disruption-reimagining-retail © 2026 EMARKETER

The GLP-1 Weight-Loss Revolution: Retail’s Next Big Disruption? | Reimagining Retail

Behind the Numbers: an EMARKETER Podcast

Join EMARKETER's The Future of Digital Summit on September 15th in New York City for a full day of research, expert analysis and executive conversations on AI visibility, commerce media and the future of marketing. Click the registration link in the show notes for tickets. Hi everyone, today is Wednesday, July 22nd. Welcome to EMARKETER's weekly retail show, Reimagining Retail. This is the show where we talk about how retail collides with every part of our lives.

And I'm your host, Suzy David-Kenyon. And on today's episode, we're exploring what happens when changing consumer behavior forces retailers to rethink the way they do their business. Joining me in the studio are podcast regular Rachel Wolf. Hey, Rachel. Rachel Wolf – Hello. And for his first time on our retail show, Rajiv Leventhal, who covers all things healthcare and pharma. Hey, Rajiv. Rajiv Leventhal – Hey, Suzy, Rachel. It's an honor to be here.

We're so excited to have you. Okay, so a recent Wall Street Journal story caught my attention. Some bridal boutiques are asking brides to sign waivers if they expect to lose weight before their wedding. So like if you're taking GLP-1s, you got to let us know. While David's Bridal just launched the exact opposite. And they're doing this whole fit guarantee. So as GLP-1s become even more accessible and mainstream, stories like this are becoming so much more common, which got us all thinking.

We spent so much time thinking about what these drugs mean to food and beverage companies and obviously healthcare. But maybe that's just too narrow. So today we're using the growing adoption of GLP-1s as a jumping off point to explore how changing consumer behaviors are reshaping the retail playbook.

The GLP-1 Weight-Loss Revolution: Retail’s Next Big Disruption? | Reimagining Retail

Read the full transcript

The candid version is on a podcast,
not the earnings call.

The GLP-1 Weight-Loss Revolution: Retail’s Next Big Disruption? | Reimagining Retail

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.